{
  "run": {
    "generated_at": "2026-01-01T20:42:12Z",
    "script": "validate_multimodal_risk.py",
    "root": "/Users/fahadkiani/Desktop/development/crispr-assistant-main/oncology-coPilot/oncology-backend-minimal/biomarker_enriched_cohorts"
  },
  "inputs": {
    "cohort_path": "/Users/fahadkiani/Desktop/development/crispr-assistant-main/oncology-coPilot/oncology-backend-minimal/biomarker_enriched_cohorts/data/tcga_ov_enriched_v2.json",
    "cohort_sha256": "11f5428eb7c3d238efa8b2329ee8f8d6942f98a162898099ad93f7b1d2f2791d",
    "endpoint": {
      "time_col": "os_days",
      "event_col": "os_event"
    },
    "tmb_threshold": 20.0,
    "hrd_high_label": "HRD-High",
    "tier_definition": {
      "Favorable": "BRCA_somatic OR (HRD-High AND (TMB-high OR MSI-H))",
      "Intermediate": "HRD-High OR TMB-high OR MSI-H",
      "Unfavorable": "else"
    }
  },
  "coverage": {
    "os_days": {
      "n": 571,
      "pct": 97.6068376068376
    },
    "os_event": {
      "n": 574,
      "pct": 98.11965811965811
    },
    "tmb": {
      "n": 523,
      "pct": 89.40170940170941
    },
    "msi_status": {
      "n": 585,
      "pct": 100.0
    },
    "hrd_proxy": {
      "n": 585,
      "pct": 100.0
    },
    "brca_somatic": {
      "n": 33,
      "pct": 5.641025641025641
    }
  },
  "usable": {
    "n": 571,
    "counts": {
      "Unfavorable": 302,
      "Intermediate": 231,
      "Favorable": 38
    }
  },
  "results": {
    "logrank_p": 0.024835377386229134,
    "test_statistic": 7.390972269594442,
    "median_days_by_tier": {
      "Favorable": 2635.0,
      "Intermediate": 1204.0,
      "Unfavorable": 1471.0
    },
    "figure": "/Users/fahadkiani/Desktop/development/crispr-assistant-main/oncology-coPilot/oncology-backend-minimal/biomarker_enriched_cohorts/figures/figure_multimodal_risk_os.png"
  },
  "notes": [
    "This is a retrospective stratification check, not proof of treatment effect.",
    "Germline BRCA is unknown in this cohort; BRCA_somatic is used as a proxy stratifier."
  ]
}
